InMed Pharmaceuticals Inc. ( INM) - Stock Earnings
INM Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
INM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.8 million USD | 1.1 million USD |
| 2026Q1 | -3.0 million USD | 659.8 million USD |
| 2026Q2 | -5.1 million USD | 2.1 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
INM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -7.7 million USD | 4.6 million USD |
| 2025 | -8.2 million USD | 4.9 million USD |
| 2026 | -12.6 million USD | 3.2 billion USD |
| 2026 Est. | — | — |
INM
Price: $1.38
52 week price:
Earnings Per Share: -2.80 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 53653
Market Capitalization: 7.3 million